Method for inducing megakaryoblast and megakaryocyte in vitro

A technique for megakaryocyte progenitor cells and megakaryocyte cells is applied in the field of inducing and differentiating mononuclear cells into megakaryocyte progenitor cells and megakaryocyte cells in vitro, which can solve the problems of low expression level and cumbersome methods.

Active Publication Date: 2010-10-20
FIELD OPERATION BLOOD TRANSFUSION INST OF PLA SCI ACAD OF MILITARY
View PDF1 Cites 20 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the method introduced in this literature is relatively cumbersome, and CD41 + Cell percentage 16....

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for inducing megakaryoblast and megakaryocyte in vitro
  • Method for inducing megakaryoblast and megakaryocyte in vitro
  • Method for inducing megakaryoblast and megakaryocyte in vitro

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

Embodiment 2

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a method for inducing megakaryoblast and megakaryocyte in vitro and a special culture medium thereof. The special culture medium is a serum free medium containing 50ng/mL of SCF, 50ng/mL of TPO, 20ng/mL of IL-3 and 50ng/mL of IL-6. The method comprises the following steps of: 1) separating single karyocyte from umbilical cord blood by using the conventional Ficoll density gradient centrifugation method, wherein red blood cells in the umbilical cord blood are settled by 6 percent hydroxyethyl starch; and 2) culturing the single karyocyte in vitro for 4 to 14 days by using the special culture medium at 37 DEG C in the presence of 5 percent CO2 to obtain a mixture of the megakaryoblast and the megakaryocyte. The invention provides a source for supplementing the megakaryoblast and the megakaryocyte, and has the advantages of simple operation, low cost, high differentiation efficiency and the like. The method is about to play an important role in the field of medicaments, and has wide application prospect.

Description

technical field The invention relates to an in vitro induction method of mononuclear cells in the field of biotechnology, in particular to a method for inducing differentiation of mononuclear cells into megakaryotic progenitor cells and megakaryocytes in vitro. Background technique Tumor is a new organism formed by the body under the action of various carcinogenic factors, a certain cell in the local tissue loses its normal regulation of its growth at the gene level, resulting in abnormal cell clonal proliferation. Tumors can be divided into benign and malignant. Malignant tumors are one of the major diseases that seriously endanger human health. The conventional treatment is still surgical treatment combined with radiotherapy and chemotherapy. After patients receive high-dose radiotherapy and chemotherapy, the hematopoietic function of the bone marrow is low, and thrombocytopenia often occurs, and in severe cases, the patient will die of hemorrhage. Platelet transfusion i...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C12N5/0786C12N5/078
CPCC12N2501/125C12N2501/145C12N5/0644C12N2501/2306C12N2500/90C12N2501/2303
Inventor 裴雪涛陈琳师伟刘大庆岳文吕洋李艳华谢小燕主鸿鹄
Owner FIELD OPERATION BLOOD TRANSFUSION INST OF PLA SCI ACAD OF MILITARY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap